European Archives - Page 563 of 1108 - European Medical Journal

EMJ Interventional Cardiology 9.1 2021 Feature Image

A Virtual Live Case of Bi/Trifurcation Percutaneous Coronary Intervention of the Left Main

The aim of the panel was to understand how to adapt treatment strategy to the underlying anatomy in a case of left main bifurcation percutaneous coronary intervention.

Surgical Treatment of Greater Saphenous Vein Thrombosis

Even surgeons are not unanimous when offering such a solution: ligation of the saphenofemoral junction (SFJ), stripping of the varicose veins, and resection of the greater saphenous vein (GSV)

EMJ Interventional Cardiology 9.1 2021 Feature Image

Left Atrial Appendage Closure for Stroke Prevention

The focus of the EuroPCR 2021 ‘Structural Theatre’ session, compared LAAC and direct oral anticoagulant (DOAC) treatment avenues for stroke prevention.

'Minimalistic Hybrid Approach' for Chronic Coronary Total Occlusions

Percutaneous treatment of chronic total occlusion (CTO) is considered one of the most challenging procedures due to the high incidence of complications and the relatively low success rate compared with non-CTO percutaneous coronary interventions (PCI).

EMJ Interventional Cardiology 9.1 2021 Feature Image

Full Bioresorbable Jacket with Magmaris™ Magnesium Scaffold: A Case Series

Bioresorbable vascular scaffolds (BRS) are a new and promising technology. BRS have been developed to provide the same advantages as drug-eluting stents, including radial strength, prevention of vessel recoil, and release of an antiproliferative drug.

EMJ Interventional Cardiology 9.1 2021 Feature Image

Coronary Flow Reserve May Be Used to Evaluate the Haemodynamic Significance of a Coronary Stenosis with Normal Fractional Flow Reserve Values: A Computational Fluid Dynamic Study

Today, coronary flow reserve (CFR) is used to evaluate the microcirculation, but not the haemodynamic significance, of coronary stenosis. Fractional flow reserve (FFR) is the gold standard for this purpose, with a cut-off value of 0.8 for intervention. Its simplicity, however, limits its predictive value.

A Rare Finding: A Left Atrial Cavernous Haemangioma

Cardiac cavernous haemangiomas are rare benign tumours more commonly seen in the right heart; this case demonstrated a LAA cavernous haemangioma, which was unusual.

Rare Right Ventricular Obstructing Myxoma: An Incidental Finding for a Common Symptom

Primary intracardiac tumours are very rare, with an incidence of 0.02% of which myxomas are the most common.1,2 Commonly affecting the mid-aged female population, myxomas are typically located within the atrium (93%) and rarely within the ventricular systems (6–8%).

EuroPCR 2021 Interview: Prof William Wijns

EuroPCR 2021 Interview: Prof William Wijns

Prof William Wijns |PCR Chairman; SFI Professor of Interventional Cardiology, National University of Ireland Galway, Galway, Ireland

EuroPCR 2021 Interview: Prof Bernard Prendergast

EuroPCR 2021 Interview: Prof Bernard Prendergast

Prof Bernard Prendergast | Course Director of PCR London Valves and Co-ordinator for Valves and Structural Activities at PCR; Professor of Interventional Cardiology and Valvular Heart Disease, Guy’s and St Thomas’ NHS Foundation Trust, London, UK